Sally Patricia Stenning
ORCID:0000-0001-7009-5488
发表论文 188 篇 · 总被引 17830 次 · h-index 54
代表论文
- Mismatch Repair Deficiency, Microsatellite Instability, and Survival (2017 · JAMA Oncology · 被引 536)
- Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial (2017 · The Lancet Oncology · 被引 292)
- Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial (2017 · The Lancet Oncology · 被引 228)
- Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial (2019 · The Lancet · 被引 223)
- Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration (2015 · Journal of Clinical Oncology · 被引 81)
- Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). (2015 · Journal of Clinical Oncology · 被引 81)